Source link : https://www.newshealth.biz/health-news/delgocitinib-takes-on-established-treatments/
AMSTERDAM — The Janus kinase inhibitor delgocitinib may be a better or comparable choice for treating hand eczema than some more established therapies, suggested the results of two separate studies presented during the late-breaking sessions at the European Academy of Dermatology and Venereology (EADV) 2024 Congress. In the 24-week, phase 3 DELTA FORCE trial, topical […]
Author : News Health
Publish date : 2024-10-08 11:09:46
Copyright for syndicated content belongs to the linked Source.